Cargando…
Cardiovascular Health Status And Genetic Risk In Survivors of Childhood Neuroblastoma and Nephroblastoma Treated With Doxorubicin: Protocol of the Pharmacogenetic Part of the LESS-Anthra Cross-Sectional Cohort Study
BACKGROUND: In childhood cancer survivors (survival of 5 years or more after diagnosis), cardiac toxicity is the most common nonmalignant cause of death attributed to treatment-related consequences. Identifying patients at risk of developing late cardiac toxicity is therefore crucial to improving tr...
Autores principales: | Zolk, Oliver, von dem Knesebeck, Annika, Graf, Norbert, Simon, Thorsten, Hero, Barbara, Abdul-Khaliq, Hashim, Abd El Rahman, Mohamed, Spix, Claudia, Mayer, Benjamin, Elsner, Susanne, Gebauer, Judith, Langer, Thorsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895281/ https://www.ncbi.nlm.nih.gov/pubmed/35175211 http://dx.doi.org/10.2196/27898 |
Ejemplares similares
-
Neuroblastoma and nephroblastoma: an overview and comparison
por: Dumba, Maureen, et al.
Publicado: (2014) -
Neuroblastoma and nephroblastoma: a radiological review
por: Dumba, Maureen, et al.
Publicado: (2015) -
The Potential Cell Population Doubling Time in Neuroblastoma and Nephroblastoma
por: Aherne, W., et al.
Publicado: (1971) -
Abdominal Radiotherapy: A Major Determinant of Metabolic Syndrome in Nephroblastoma and Neuroblastoma Survivors
por: van Waas, Marjolein, et al.
Publicado: (2012) -
Extrarenal Nephroblastoma
por: Teerthanath, S
Publicado: (2011)